sacituzumab,enfortumab,vedolizumab
gilead,astellas,seagen,takeda
['#unite', 'sacituzumab', 'biomarker', 'urothelial', 'enfortumab', 'unite study', ' vedo', 'sacitu, govi']
biomarkers of response to sacituzumab govitecan and efficacy after treatment with enfortumab vedotin in advanced #urothelialcarcinoma: analysis of the #unite study. presented by . #asco23 coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology